메뉴 건너뛰기




Volumn 162, Issue 11, 2015, Pages 765-776

Screening for type 2 diabetes mellitus: A systematic review for the U.S. preventive services task force

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR MORTALITY; DISEASE COURSE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING; SYSTEMATIC REVIEW; ADULT; ADVERSE EFFECTS; ASYMPTOMATIC DISEASE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; EARLY DIAGNOSIS; GLUCOSE INTOLERANCE; LIFESTYLE; MASS SCREENING; MORTALITY; RISK ASSESSMENT; UNITED STATES;

EID: 84932125338     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-2221     Document Type: Review
Times cited : (108)

References (93)
  • 1
    • 84906978168 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention. Atlanta, GA: U.S. Dept of Health and Human Services on 20 August 2014
    • Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U.S. Dept of Health and Human Services; 2014. Accessed at www.cdc.gov/diabetes/pubs/fact sheet11.htm on 20 August 2014.
    • (2014) National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States 2014
  • 2
    • 84871941957 scopus 로고    scopus 로고
    • Diagnosis and classification of diabetes mellitus
    • American Diabetes Association
    • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36 Suppl 1:S67-74. doi:10.2337/dc13-S067
    • (2013) Diabetes Care , vol.36 , pp. S67-74
  • 3
    • 84870933872 scopus 로고    scopus 로고
    • Increasing prevalence of diagnosed diabetes-United States and Puerto Rico 1995-2010
    • Centers for Disease Control and Prevention (CDC)
    • Centers for Disease Control and Prevention (CDC). Increasing prevalence of diagnosed diabetes-United States and Puerto Rico, 1995-2010. MMWR Morb Mortal Wkly Rep. 2012;61:918-21.
    • (2012) MMWR Morb Mortal Wkly Rep , vol.61 , pp. 918-921
  • 4
    • 0033854620 scopus 로고    scopus 로고
    • Early detection of undiagnosed diabetes mellitus: A U.S. Perspective
    • Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a U.S. perspective. Diabetes Metab Res Rev. 2000;16:230-6.
    • (2000) Diabetes Metab Res Rev , vol.16 , pp. 230-236
    • Harris, M.I.1    Eastman, R.C.2
  • 5
    • 11944263528 scopus 로고
    • Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis
    • Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992; 15:815-9.
    • (1992) Diabetes Care , vol.15 , pp. 815-819
    • Harris, M.I.1    Klein, R.2    Welborn, T.A.3    Knuiman, M.W.4
  • 6
    • 84892649479 scopus 로고    scopus 로고
    • Standards of medical care in diabetes-2014
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37 Suppl 1:S14-80. doi:10.2337/dc14-S014
    • (2014) Diabetes Care , vol.37 , pp. S14-80
  • 7
    • 0037034257 scopus 로고    scopus 로고
    • Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
    • Diabetes Prevention Program Research Group
    • Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
    • (2002) N Engl J Med , vol.346 , pp. 393-403
    • Knowler, W.C.1    Barrett-Connor, E.2    Fowler, S.E.3    Hamman, R.F.4    Lachin, J.M.5    Walker, E.A.6
  • 8
    • 11844305996 scopus 로고    scopus 로고
    • Prevention of type 2 diabetes by lifestyle intervention: A Japanese trial in IGT males
    • Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract. 2005;67:152-62.
    • (2005) Diabetes Res Clin Pract , vol.67 , pp. 152-162
    • Kosaka, K.1    Noda, M.2    Kuzuya, T.3
  • 9
    • 0035799806 scopus 로고    scopus 로고
    • Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
    • Finnish Diabetes Prevention Study Group
    • Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hama la inen H, Ilanne-Parikka P, et al; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344: 1343-50.
    • (2001) N Engl J Med , vol.344 , pp. 1343-1350
    • Tuomilehto, J.1    Lindstrom, J.2    Eriksson, J.G.3    Valle, T.T.4    Hamalainen, H.5    Ilanne-Parikka, P.6
  • 11
    • 0344412861 scopus 로고    scopus 로고
    • Randomized controlled trial of a new dietary education program to prevent type 2 diabetes in a high-risk group of Japanese male workers
    • Watanabe M, Yamaoka K, Yokotsuka M, Tango T. Randomized controlled trial of a new dietary education program to prevent type 2 diabetes in a high-risk group of Japanese male workers. Diabetes Care. 2003;26:3209-14.
    • (2003) Diabetes Care , vol.26 , pp. 3209-3214
    • Watanabe, M.1    Yamaoka, K.2    Yokotsuka, M.3    Tango, T.4
  • 12
    • 0034820062 scopus 로고    scopus 로고
    • Long-Term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance
    • Swinburn BA, Metcalf PA, Ley SJ. Long-Term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care. 2001;24:619-24.
    • (2001) Diabetes Care , vol.24 , pp. 619-624
    • Swinburn, B.A.1    Metcalf, P.A.2    Ley, S.J.3
  • 13
    • 0030935652 scopus 로고    scopus 로고
    • Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance
    • The Da Qing IGT and Diabetes Study
    • Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-44.
    • (1997) Diabetes Care , vol.20 , pp. 537-544
    • Pan, X.R.1    Li, G.W.2    Hu, Y.H.3    Wang, J.X.4    Yang, W.Y.5    An, Z.X.6
  • 14
    • 0031421293 scopus 로고    scopus 로고
    • Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose
    • The Fasting Hyperglycaemia Study: II
    • Dyson PA, Hammersley MS, Morris RJ, Holman RR, Turner RC. The Fasting Hyperglycaemia Study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose. Metabolism. 1997;46:50-5.
    • (1997) Metabolism , vol.46 , pp. 50-55
    • Dyson, P.A.1    Hammersley, M.S.2    Morris, R.J.3    Holman, R.R.4    Turner, R.C.5
  • 15
    • 84930465070 scopus 로고    scopus 로고
    • Standards of medical care in diabetes-2015
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care. 2015;38 Suppl 1:S1-94.
    • (2015) Diabetes Care , vol.38 , pp. S1-94
  • 16
    • 84855539606 scopus 로고    scopus 로고
    • American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan
    • AACE Task Force for Developing Diabetes Comprehensive Care Plan
    • Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, et al; AACE Task Force for Developing Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17 Suppl 2:1-53.
    • (2011) Endocr Pract. , vol.17 , pp. 1-53
    • Handelsman, Y.1    Mechanick, J.I.2    Blonde, L.3    Grunberger, G.4    Bloomgarden, Z.T.5    Bray, G.A.6
  • 17
    • 33749612667 scopus 로고    scopus 로고
    • American Academy of Family Physicians Leawood, KS: American Acad Family Physicians
    • American Academy of Family Physicians. Summary of Recommendations for Clinical Preventive Services. Leawood, KS: American Acad Family Physicians; 2012:19.
    • (2012) Summary of Recommendations for Clinical Preventive Services , pp. 19
  • 20
    • 84868143092 scopus 로고    scopus 로고
    • Recommendations on screening for type 2 diabetes in adults
    • Canadian Task Force on Preventive Health Care
    • Pottie K, Jaramillo A, Lewin G, Dickinson J, Bell N, Brauer P, et al; Canadian Task Force on Preventive Health Care. Recommendations on screening for type 2 diabetes in adults. CMAJ. 2012;184:1687-96. doi:10.1503/cmaj.120732
    • (2012) CMAJ , vol.184 , pp. 1687-1696
    • Pottie, K.1    Jaramillo, A.2    Lewin, G.3    Dickinson, J.4    Bell, N.5    Brauer, P.6
  • 21
    • 0037418125 scopus 로고    scopus 로고
    • Screening adults for type 2 diabetes: A review of the evidence for the U.S Preventive Services Task Force
    • Harris R, Donahue K, Rathore SS, Frame P, Woolf SH, Lohr KN. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138:215-29.
    • (2003) Ann Intern Med , vol.138 , pp. 215-229
    • Harris, R.1    Donahue, K.2    Rathore, S.S.3    Frame, P.4    Woolf, S.H.5    Lohr, K.N.6
  • 22
    • 84932130471 scopus 로고    scopus 로고
    • Screening for Type 2 Diabetes: Update of 2003 Systematic Evidence Review for the U.S. Preventive Services Task Force AHRQ publication no. 08-05116-EF-1. Rockville MD Agency for Healthcare Research and Quality
    • Norris SL, Kansagara D, Bougatsos C, Nygren P, Fu R. Screening for Type 2 Diabetes: Update of 2003 Systematic Evidence Review for the U.S. Preventive Services Task Force. Evidence synthesis no. 61. AHRQ publication no. 08-05116-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
    • (2008) Evidence Synthesis , vol.61
    • Norris, S.L.1    Kansagara, D.2    Bougatsos, C.3    Nygren, P.4    Fu, R.5
  • 23
    • 44649126707 scopus 로고    scopus 로고
    • U.S. Preventive Services Task Force. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force
    • Norris SL, Kansagara D, Bougatsos C, Fu R; U.S. Preventive Services Task Force. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;148:855-68.
    • (2008) Ann Intern Med , vol.148 , pp. 855-868
    • Norris, S.L.1    Kansagara, D.2    Bougatsos, C.3    Fu, R.4
  • 24
    • 84932111070 scopus 로고    scopus 로고
    • Screening for Type 2 Diabetes Mellitus: Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation AHRQ publication no. 3-05190-EF-1. Rockville MD Agency for Healthcare Research and Quality
    • Selph S, Dana T, Blazina I, Bougatsos C, Patel H, Chou R. Screening for Type 2 Diabetes Mellitus: Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation. Evidence synthesis no. 117. AHRQ publication no. 3-05190-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2014.
    • (2014) Evidence Synthesis , vol.117
    • Selph, S.1    Dana, T.2    Blazina, I.3    Bougatsos, C.4    Patel, H.5    Chou, R.6
  • 25
    • 34848863268 scopus 로고    scopus 로고
    • U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Procedure Manual. AHRQ publication no. 08-05118-EF. Rockville, MD on 28 October 2014
    • U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Procedure Manual. AHRQ publication no. 08-05118-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2008. Accessed at www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual.htm on 28 October 2014.
    • (2008) Agency for Healthcare Research and Quality
  • 28
    • 77951473452 scopus 로고    scopus 로고
    • Effect of nateglinide on the incidence of diabetes and cardiovascular events
    • NAVIGATOR Study Group
    • Holman RR, Haffner SM, McMurray JJ, Bethel MA, Holzhauer B, Hua TA, et al; NAVIGATOR Study Group. Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010;362:1463-76. doi:10.1056/NEJMoa1001122
    • (2011) N Engl J Med , vol.362 , pp. 1463-1476
    • Holman, R.R.1    Haffner, S.M.2    McMurray, J.J.3    Bethel, M.A.4    Holzhauer, B.5    Hua, T.A.6
  • 29
    • 77951453096 scopus 로고    scopus 로고
    • Effect of valsartan on the incidence of diabetes and cardiovascular events
    • NAVIGATOR Study Group
    • McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, et al; NAVIGATOR Study Group. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med. 2010;362:1477-90. doi:10.1056/NEJMoa1001121
    • (2011) N Engl J Med , vol.362 , pp. 1477-1490
    • McMurray, J.J.1    Holman, R.R.2    Haffner, S.M.3    Bethel, M.A.4    Holzhauer, B.5    Hua, T.A.6
  • 30
    • 48649107300 scopus 로고    scopus 로고
    • Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
    • DREAM Trial Investigators
    • Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, et al; DREAM Trial Investigators. Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetes Care. 2008;31:1007-14. doi:10.2337/dc07-1868
    • (2008) Diabetes Care , vol.31 , pp. 1007-1014
    • Dagenais, G.R.1    Gerstein, H.C.2    Holman, R.3    Budaj, A.4    Escalante, A.5    Hedner, T.6
  • 31
    • 80053351531 scopus 로고    scopus 로고
    • Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program
    • Fu R, Gartlehner G, Grant M, Shamliyan T, Sedrakyan A, Wilt TJ, et al. Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program. J Clin Epidemiol. 2011;64:1187-97. doi:10.1016/j .jclinepi.2010.08.010
    • (2011) J Clin Epidemiol , vol.64 , pp. 1187-1197
    • Fu, R.1    Gartlehner, G.2    Grant, M.3    Shamliyan, T.4    Sedrakyan, A.5    Wilt, T.J.6
  • 32
    • 84869094223 scopus 로고    scopus 로고
    • Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): A clusterrandomised controlled trial
    • Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a clusterrandomised controlled trial. Lancet. 2012;380:1741-8. doi:10.1016/S0140-6736(12)61422-6
    • (2012) Lancet , vol.380 , pp. 1741-1748
    • Simmons, R.K.1    Echouffo-Tcheugui, J.B.2    Sharp, S.J.3    Sargeant, L.A.4    Williams, K.M.5    Prevost, A.T.6
  • 33
    • 78951476112 scopus 로고    scopus 로고
    • Effect of population screening for type 2 diabetes on mortality: Long-Term follow-up of the Ely cohort
    • Simmons RK, Rahman M, Jakes RW, Yuyun MF, Niggebrugge AR, Hennings SH, et al. Effect of population screening for type 2 diabetes on mortality: long-Term follow-up of the Ely cohort. Diabetologia. 2011;54:312-9. doi:10.1007/s00125-010-1949-8
    • (2011) Diabetologia , vol.54 , pp. 312-319
    • Simmons, R.K.1    Rahman, M.2    Jakes, R.W.3    Yuyun, M.F.4    Niggebrugge, A.R.5    Hennings, S.H.6
  • 34
    • 0033808127 scopus 로고    scopus 로고
    • The ADDITION study: Proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening
    • Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care
    • Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G; Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord. 2000;24 Suppl 3:S6-11.
    • (2000) Int J Obes Relat Metab Disord , vol.24 , pp. S6-11
    • Lauritzen, T.1    Griffin, S.2    Borch-Johnsen, K.3    Wareham, N.J.4    Wolffenbuttel, B.H.5    Rutten, G.6
  • 35
    • 53949086488 scopus 로고    scopus 로고
    • Screening for type 2 diabetes is feasible, acceptable, but associated with increased shortterm anxiety: A randomised controlled trial in British general practice
    • Park P, Simmons RK, Prevost AT, Griffin SJ. Screening for type 2 diabetes is feasible, acceptable, but associated with increased shortterm anxiety: a randomised controlled trial in British general practice. BMC Public Health. 2008;8:350. doi:10.1186/1471-2458-8-350
    • (2008) BMC Public Health , vol.8 , Issue.350
    • Park, P.1    Simmons, R.K.2    Prevost, A.T.3    Griffin, S.J.4
  • 36
    • 84862661244 scopus 로고    scopus 로고
    • Effect of screening for type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort
    • Rahman M, Simmons RK, Hennings SH, Wareham NJ, Griffin SJ. Effect of screening for type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort. Diabet Med. 2012;29:886-92. doi:10.1111/j.1464-5491.2012.03570.x
    • (2012) Diabet Med , vol.29 , pp. 886-892
    • Rahman, M.1    Simmons, R.K.2    Hennings, S.H.3    Wareham, N.J.4    Griffin, S.J.5
  • 37
    • 79951660099 scopus 로고    scopus 로고
    • Predictors of anxiety and depression among people attending diabetes screening: A prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial
    • Paddison CA, Eborall HC, French DP, Kinmonth AL, Prevost AT, Griffin SJ, et al. Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial. Br J Health Psychol. 2011;16:213-26. doi:10.1348/135910710X495366
    • (2011) Br J Health Psychol , vol.16 , pp. 213-226
    • Paddison, C.A.1    Eborall, H.C.2    French, D.P.3    Kinmonth, A.L.4    Prevost, A.T.5    Griffin, S.J.6
  • 38
    • 84901590227 scopus 로고    scopus 로고
    • Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the da Qing Diabetes Prevention Study: A 23-year follow-up study
    • Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014;2:474-80. doi: 10.1016/S2213-8587(14)70057-9
    • (2014) Lancet Diabetes Endocrinol , vol.2 , pp. 474-480
    • Li, G.1    Zhang, P.2    Wang, J.3    An, Y.4    Gong, Q.5    Gregg, E.W.6
  • 39
    • 43849111166 scopus 로고    scopus 로고
    • The long-Term effect of lifestyle interventions to prevent diabetes in the China da Qing Diabetes Prevention Study: A 20-year follow-up study
    • Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-Term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371:1783-9. doi:10.1016/S0140-6736(08)60766-7
    • (2008) Lancet , vol.371 , pp. 1783-1789
    • Li, G.1    Zhang, P.2    Wang, J.3    Gregg, E.W.4    Yang, W.5    Gong, Q.6
  • 40
    • 80051626229 scopus 로고    scopus 로고
    • Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: A randomized controlled trial
    • Zensharen Study for Prevention of Lifestyle Diseases Group
    • Saito T, Watanabe M, Nishida J, Izumi T, Omura M, Takagi T, et al; Zensharen Study for Prevention of Lifestyle Diseases Group. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med. 2011;171:1352-60. doi:10.1001/archinternmed.2011.275
    • (2011) Arch Intern Med , vol.171 , pp. 1352-1360
    • Saito, T.1    Watanabe, M.2    Nishida, J.3    Izumi, T.4    Omura, M.5    Takagi, T.6
  • 41
    • 66249112528 scopus 로고    scopus 로고
    • Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study-secondary analysis of the randomized trial
    • Finnish Diabetes Prevention Study Group
    • Uusitupa M, Peltonen M, LindstromJ, Aunola S, Ilanne-Parikka P, Keina nen-Kiukaanniemi S, et al; Finnish Diabetes Prevention Study Group. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study-secondary analysis of the randomized trial. PLoS One. 2009;4:e5656. doi:10.1371/journal.pone.0005656
    • (2009) PLoS One , vol.4 , pp. e5656
    • Uusitupa, M.1    Peltonen, M.2    Lindstromj Aunola, S.3    Ilanne-Parikka, P.4    Keina Nen-Kiukaanniemi, S.5
  • 42
    • 79960268164 scopus 로고    scopus 로고
    • Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: The Early ACTID randomised controlled trial
    • Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial. Lancet. 2011;378:129-39. doi:10.1016/S0140-6736(11)60442-X
    • (2011) Lancet , vol.378 , pp. 129-139
    • Andrews, R.C.1    Cooper, A.R.2    Montgomery, A.A.3    Norcross, A.J.4    Peters, T.J.5    Sharp, D.J.6
  • 43
    • 40449107710 scopus 로고    scopus 로고
    • Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: Cluster randomised controlled trial
    • Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative
    • Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al; Diabetes Education and Self Management for Ongoing and Newly Diagnosed Collaborative. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ. 2008;336:491-5. doi:10.1136/bmj.39474 .922025.BE
    • (2008) BMJ , vol.336 , pp. 491-495
    • Davies, M.J.1    Heller, S.2    Skinner, T.C.3    Campbell, M.J.4    Carey, M.E.5    Cradock, S.6
  • 44
    • 84862139392 scopus 로고    scopus 로고
    • Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: Three year follow-up of a cluster randomised controlled trial in primary care
    • Khunti K, Gray LJ, Skinner T, Carey ME, Realf K, Dallosso H, et al. Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. BMJ. 2012;344:e2333. doi:10.1136/bmj.e2333
    • (2012) BMJ , vol.344 , pp. e2333
    • Khunti, K.1    Gray, L.J.2    Skinner, T.3    Carey, M.E.4    Realf, K.5    Dallosso, H.6
  • 45
    • 79953232077 scopus 로고    scopus 로고
    • Pioglitazone for diabetes prevention in impaired glucose tolerance
    • ACT NOW Study
    • DeFronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, et al; ACT NOW Study. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med. 2011;364: 1104-15. doi:10.1056/NEJMoa1010949
    • (2011) N Engl J Med , vol.364 , pp. 1104-1115
    • Defronzo, R.A.1    Tripathy, D.2    Schwenke, D.C.3    Banerji, M.4    Bray, G.A.5    Buchanan, T.A.6
  • 46
    • 65449150953 scopus 로고    scopus 로고
    • Voglibose for prevention of type 2 diabetes mellitus: A randomised, double-blind trial in Japa-nese individuals with impaired glucose tolerance
    • Voglibose Ph-3 Study Group
    • Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, Kaku K; Voglibose Ph-3 Study Group. Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japa-nese individuals with impaired glucose tolerance. Lancet. 2009;373: 1607-14. doi:10.1016/S0140-6736(09)60222-1
    • (2009) Lancet , vol.373 , pp. 1607-1614
    • Kawamori, R.1    Tajima, N.2    Iwamoto, Y.3    Kashiwagi, A.4    Shimamoto, K.5    Kaku, K.6
  • 47
    • 60849095141 scopus 로고    scopus 로고
    • A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: The Dutch acarbose intervention study in persons with impaired glucose tolerance (DAISI)
    • Nijpels G, Boorsma W, Dekker JM, Kostense PJ, Bouter LM, Heine RJ. A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: the Dutch acarbose intervention study in persons with impaired glucose tolerance (DAISI). Diabetes Metab Res Rev. 2008;24:611-6. doi:10.1002/dmrr.839
    • (2008) Diabetes Metab Res Rev , vol.24 , pp. 611-616
    • Nijpels, G.1    Boorsma, W.2    Dekker, J.M.3    Kostense, P.J.4    Bouter, L.M.5    Heine, R.J.6
  • 48
    • 67349125192 scopus 로고    scopus 로고
    • Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: Results of the Indian Diabetes Prevention Programme-2 (IDPP-2)
    • Ramachandran A, Snehalatha C, Mary S, Selvam S, Kumar CK, Seeli AC, et al. Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia. 2009;52:1019-26. doi:10.1007/s00125-009-1315-x
    • (2009) Diabetologia , vol.52 , pp. 1019-1026
    • Ramachandran, A.1    Snehalatha, C.2    Mary, S.3    Selvam, S.4    Kumar, C.K.5    Seeli, A.C.6
  • 49
    • 77955013179 scopus 로고    scopus 로고
    • Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): A double-blind randomised controlled study
    • Zinman B, Harris SB, Neuman J, Gerstein HC, Retnakaran RR, Raboud J, et al. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. Lancet. 2010;376:103-11. doi:10.1016/S0140-6736(10)60746-5
    • (2011) Lancet , vol.376 , pp. 103-111
    • Zinman, B.1    Harris, S.B.2    Neuman, J.3    Gerstein, H.C.4    Retnakaran, R.R.5    Raboud, J.6
  • 50
    • 85028123837 scopus 로고    scopus 로고
    • Diabetes Prevention Program Research Group. Impact of lifestyle intervention and metformin on health-related quality of life: The diabetes prevention program randomized trial
    • Florez H, Pan Q, Ackermann RT, Marrero DG, Barrett-Connor E, Delahanty L, et al; Diabetes Prevention Program Research Group. Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial. J Gen Intern Med. 2012;27:1594-601. doi:10.1007/s11606-012-2122-5
    • (2012) J Gen Intern Med , vol.27 , pp. 1594-1601
    • Florez, H.1    Pan, Q.2    Ackermann, R.T.3    Marrero, D.G.4    Barrett-Connor, E.5    Delahanty, L.6
  • 51
    • 0037097039 scopus 로고    scopus 로고
    • Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial
    • STOP-NIDDM Trial Research Group
    • Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359:2072-7.
    • (2002) Lancet , vol.359 , pp. 2072-2077
    • Chiasson, J.L.1    Josse, R.G.2    Gomis, R.3    Hanefeld, M.4    Karasik, A.5    Laakso, M.6
  • 52
    • 33748748206 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomised controlled trial
    • DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators
    • Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, et al; DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368:1096-105.
    • (2006) Lancet , vol.368 , pp. 1096-1105
    • Gerstein, H.C.1    Yusuf, S.2    Bosch, J.3    Pogue, J.4    Sheridan, P.5    Dinccag, N.6
  • 53
    • 0038455703 scopus 로고    scopus 로고
    • Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: The STOP-NIDDM trial
    • STOP-NIDDM Trial Research Group
    • Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003;290: 486-94.
    • (2003) JAMA , vol.290 , pp. 486-494
    • Chiasson, J.L.1    Josse, R.G.2    Gomis, R.3    Hanefeld, M.4    Karasik, A.5    Laakso, M.6
  • 54
    • 15944424370 scopus 로고    scopus 로고
    • Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program
    • Diabetes Prevention Program Research Group
    • Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, et al; Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care. 2005;28:888-94.
    • (2005) Diabetes Care , vol.28 , pp. 888-894
    • Ratner, R.1    Goldberg, R.2    Haffner, S.3    Marcovina, S.4    Orchard, T.5    Fowler, S.6
  • 55
    • 79960245269 scopus 로고    scopus 로고
    • Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): A cluster-randomised trial
    • Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE, Sandb A, et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet. 2011;378:156-67. doi:10.1016/S0140-6736(11)60698-3
    • (2011) Lancet , vol.378 , pp. 156-167
    • Griffin, S.J.1    Borch-Johnsen, K.2    Davies, M.J.3    Khunti, K.4    Rutten, G.E.5    Sandb, A.6
  • 56
    • 84867201468 scopus 로고    scopus 로고
    • Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial
    • Simmons RK, Sharp SJ, Sandb A, Borch-Johnsen K, Davies MJ, Khunti K, et al. Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial. Diabet Med. 2012;29:e409-16. doi:10.1111/j.1464-5491.2012.03759.x
    • (2012) Diabet Med , vol.29 , pp. e409-e416
    • Simmons, R.K.1    Sharp, S.J.2    Sandb, A.3    Borch-Johnsen, K.4    Davies, M.J.5    Khunti, K.6
  • 57
    • 84885872497 scopus 로고    scopus 로고
    • Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITIONEurope): A cluster-randomised trial
    • Van den Donk M, Griffin SJ, Stellato RK, Simmons RK, Sandb A, Lauritzen T, et al. Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITIONEurope): a cluster-randomised trial. Diabetologia. 2013.
    • (2013) Diabetologia
    • Van Den Donk, M.1    Griffin, S.J.2    Stellato, R.K.3    Simmons, R.K.4    Sandb, A.5    Lauritzen, T.6
  • 58
    • 84876470665 scopus 로고    scopus 로고
    • Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: A systematic review with meta-analysis of randomized controlled trials
    • Buehler AM, Cavalcanti AB, Berwanger O, Figueiro M, Laranjeira LN, Zazula AD, et al. Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Cardiovasc Ther. 2013;31:147-60. doi:10.1111/j.1755-5922.2011.00308.x
    • (2013) Cardiovasc Ther , vol.31 , pp. 147-160
    • Buehler, A.M.1    Cavalcanti, A.B.2    Berwanger, O.3    Figueiro, M.4    Laranjeira, L.N.5    Zazula, A.D.6
  • 59
    • 77950127970 scopus 로고    scopus 로고
    • Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
    • Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013;11:CD008143. doi:10.1002/14651858.CD008143.pub3
    • (2013) Cochrane Database Syst Rev , vol.11 , pp. CD008143
    • Hemmingsen, B.1    Lund, S.S.2    Gluud, C.3    Vaag, A.4    Almdal, T.P.5    Hemmingsen, C.6
  • 60
    • 82755165018 scopus 로고    scopus 로고
    • Intensive glycaemic control for patients with type 2 diabetes: Systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
    • Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, et al. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ. 2011;343:d6898. doi:10.1136/bmj.d6898
    • (2011) BMJ , vol.343 , pp. d6898
    • Hemmingsen, B.1    Lund, S.S.2    Gluud, C.3    Vaag, A.4    Almdal, T.5    Hemmingsen, C.6
  • 61
    • 79960959816 scopus 로고    scopus 로고
    • Effect of intensive glucose lowering treatment on all-cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: Meta-analysis of randomised controlled trials
    • Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassai B, et al. Effect of intensive glucose lowering treatment on all-cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ. 2011;343:d4169. doi:10.1136/bmj.d4169
    • (2011) BMJ , vol.343 , pp. d4169
    • Boussageon, R.1    Bejan-Angoulvant, T.2    Saadatian-Elahi, M.3    Lafont, S.4    Bergeonneau, C.5    Kassai, B.6
  • 62
    • 79952276236 scopus 로고    scopus 로고
    • Intensive glycemic control and macrovascular events in type 2 diabetes mellitus: A metaanalysis of randomized controlled trials
    • Wu H, Xu MJ, Zou DJ, Han QJ, Hu X. Intensive glycemic control and macrovascular events in type 2 diabetes mellitus: a metaanalysis of randomized controlled trials. Chin Med J (Engl). 2010; 123:2908-13.
    • (2011) Chin Med J (Engl) , vol.123 , pp. 2908-2913
    • Wu, H.1    Xu, M.J.2    Zou, D.J.3    Han, Q.J.4    Hu, X.5
  • 64
    • 65649106228 scopus 로고    scopus 로고
    • Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A metaanalysis of randomised controlled trials
    • Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a metaanalysis of randomised controlled trials. Lancet. 2009;373:1765-72. doi:10.1016/S0140-6736(09)60697-8
    • (2009) Lancet , vol.373 , pp. 1765-1772
    • Ray, K.K.1    Seshasai, S.R.2    Wijesuriya, S.3    Sivakumaran, R.4    Nethercott, S.5    Preiss, D.6
  • 65
    • 70350567207 scopus 로고    scopus 로고
    • The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: A meta-analysis
    • Ma J, Yang W, Fang N, Zhu W, Wei M. The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis. Nutr Metab Cardiovasc Dis. 2009;19: 596-603. doi:10.1016/j.numecd.2009.07.004
    • (2009) Nutr Metab Cardiovasc Dis , vol.19 , pp. 596-603
    • Ma, J.1    Yang, W.2    Fang, N.3    Zhu, W.4    Wei, M.5
  • 66
    • 68349130799 scopus 로고    scopus 로고
    • Prevention of cardiovascular disease through glycemic control in type 2 diabetes: A meta-analysis of randomized clinical trials
    • Mannucci E, Monami M, Lamanna C, Gori F, Marchionni N. Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 2009;19:604-12. doi:10.1016/j .numecd.2009.03.021
    • (2009) Nutr Metab Cardiovasc Dis , vol.19 , pp. 604-612
    • Mannucci, E.1    Monami, M.2    Lamanna, C.3    Gori, F.4    Marchionni, N.5
  • 67
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • Action to Control Cardiovascular Risk in Diabetes Study Group
    • Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-59. doi:10.1056/NEJMoa0802743
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
    • Gerstein, H.C.1    Miller, M.E.2    Byington, R.P.3    Goff, D.C.4    Bigger, J.T.5    Buse, J.B.6
  • 68
    • 70449360911 scopus 로고    scopus 로고
    • Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial
    • ADVANCE Collaborative Group
    • Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, et al; ADVANCE Collaborative Group. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from the ADVANCE trial. Diabetes Care. 2009; 32:2068-74. doi:10.2337/dc09-0959
    • (2009) Diabetes Care , vol.32 , pp. 2068-2074
    • Zoungas, S.1    De Galan, B.E.2    Ninomiya, T.3    Grobbee, D.4    Hamet, P.5    Heller, S.6
  • 69
    • 58149389215 scopus 로고    scopus 로고
    • Glucose control and vascular complications in veterans with type 2 diabetes
    • VADT Investigators
    • Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360: 129-39. doi:10.1056/NEJMoa0808431
    • (2009) N Engl J Med , vol.360 , pp. 129-139
    • Duckworth, W.1    Abraira, C.2    Moritz, T.3    Reda, D.4    Emanuele, N.5    Reaven, P.D.6
  • 70
    • 79959504988 scopus 로고    scopus 로고
    • Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: Observations from traditional and Bayesian random -effects meta-analyses of randomized trials
    • Bangalore S, Kumar S, Lobach I, Messerli FH. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and Bayesian random-effects meta-analyses of randomized trials. Circulation. 2011;123:2799-810. doi:10.1161/CIRCULATIONAHA.110.016337
    • (2011) Circulation , vol.123 , pp. 2799-2810
    • Bangalore, S.1    Kumar, S.2    Lobach, I.3    Messerli, F.H.4
  • 71
    • 77951735232 scopus 로고    scopus 로고
    • Effects of intensive bloodpressure control in type 2 diabetes mellitus
    • ACCORD Study Group
    • Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al; ACCORD Study Group. Effects of intensive bloodpressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362:1575-85. doi:10.1056/NEJMoa1001286
    • (2011) N Engl J Med , vol.362 , pp. 1575-1585
    • Cushman, W.C.1    Evans, G.W.2    Byington, R.P.3    Goff, D.C.4    Grimm, R.H.5    Cutler, J.A.6
  • 72
    • 34548420712 scopus 로고    scopus 로고
    • Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial
    • ADVANCE Collaborative Group
    • Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al; ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829-40.
    • (2007) Lancet , vol.370 , pp. 829-840
    • Patel, A.1    Macmahon, S.2    Chalmers, J.3    Neal, B.4    Woodward, M.5    Billot, L.6
  • 73
    • 68049124872 scopus 로고    scopus 로고
    • Blood pressure and glucose control in subjects with diabetes: New analyses from ADVANCE
    • Poulter NR. Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE. J Hypertens Suppl. 2009; 27:S3-8. doi:10.1097/01.hjh.0000354417.70192.be
    • (2009) J Hypertens Suppl , vol.27 , pp. S3-8
    • Poulter, N.R.1
  • 74
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and lowdose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • HOT Study Group
    • Hansson L, Zanchetti A, Carruthers SG, Dahlo f B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and lowdose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755-62.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlof, B.4    Elmfeldt, D.5    Julius, S.6
  • 75
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-13.
    • (1998) BMJ , vol.317 , pp. 703-713
  • 76
    • 53749091595 scopus 로고    scopus 로고
    • Longterm follow-up after tight control of blood pressure in type 2 diabetes
    • Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Longterm follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359:1565-76. doi:10 .1056/NEJMoa0806359
    • (2008) N Engl J Med , vol.359 , pp. 1565-1576
    • Holman, R.R.1    Paul, S.K.2    Bethel, M.A.3    Neil, H.A.4    Matthews, D.R.5
  • 77
    • 0032485350 scopus 로고    scopus 로고
    • The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
    • Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med. 1998;338:645-52.
    • (1998) N Engl J Med , vol.338 , pp. 645-652
    • Estacio, R.O.1    Jeffers, B.W.2    Hiatt, W.R.3    Biggerstaff, S.L.4    Gifford, N.5    Schrier, R.W.6
  • 78
    • 0036190137 scopus 로고    scopus 로고
    • Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes
    • Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61:1086-97.
    • (2002) Kidney Int , vol.61 , pp. 1086-1097
    • Schrier, R.W.1    Estacio, R.O.2    Esler, A.3    Mehler, P.4
  • 79
    • 34547232484 scopus 로고    scopus 로고
    • Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: A summary of the ABCD trial
    • Schrier RW, Estacio RO, Mehler PS, Hiatt WR. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nat Clin Pract Nephrol. 2007; 3:428-38.
    • (2007) Nat Clin Pract Nephrol , vol.3 , pp. 428-438
    • Schrier, R.W.1    Estacio, R.O.2    Mehler, P.S.3    Hiatt, W.R.4
  • 80
    • 58149494663 scopus 로고    scopus 로고
    • Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION-Netherlands study
    • Janssen PG, Gorter KJ, Stolk RP, Rutten GE. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION-Netherlands study. Br J Gen Pract. 2009;59:43-8. doi:10.3399/bjgp09X394851
    • (2009) Br J Gen Pract , vol.59 , pp. 43-48
    • Janssen, P.G.1    Gorter, K.J.2    Stolk, R.P.3    Rutten, G.E.4
  • 81
    • 41949101956 scopus 로고    scopus 로고
    • Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: The SANDS randomized trial
    • Howard BV, Roman MJ, Devereux RB, Fleg JL, Galloway JM, Henderson JA, et al. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA. 2008;299:1678-89. doi:10.1001/jama.299.14.1678
    • (2008) JAMA , vol.299 , pp. 1678-1689
    • Howard, B.V.1    Roman, M.J.2    Devereux, R.B.3    Fleg, J.L.4    Galloway, J.M.5    Henderson, J.A.6
  • 82
    • 38949210220 scopus 로고    scopus 로고
    • Effect of a multifactorial intervention on mortality in type 2 diabetes
    • Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580-91. doi:10.1056/NEJMoa0706245
    • (2008) N Engl J Med , vol.358 , pp. 580-591
    • Gaede, P.1    Lund-Andersen, H.2    Parving, H.H.3    Pedersen, O.4
  • 83
    • 79958185431 scopus 로고    scopus 로고
    • Outcome of intensive integrated intervention in participants with impaired glucose regulation in China
    • Lu YH, Lu JM, Wang SY, Li CL, Zheng RP, Tian H, et al. Outcome of intensive integrated intervention in participants with impaired glucose regulation in China. Adv Ther. 2011;28:511-9. doi:10.1007/s12325-011-0022-4
    • (2011) Adv Ther , vol.28 , pp. 511-519
    • Lu, Y.H.1    Lu, J.M.2    Wang, S.Y.3    Li, C.L.4    Zheng, R.P.5    Tian, H.6
  • 84
    • 70350022412 scopus 로고    scopus 로고
    • Prevention of type 2 diabetes in adults with impaired glucose tolerance: The European Diabetes Prevention RCT in Newcastle upon Tyne UK
    • Penn L, White M, Oldroyd J, Walker M, Alberti KG, Mathers JC. Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK. BMC Public Health. 2009;9:342. doi: 10.1186/1471-2458-9-342
    • (2009) BMC Public Health , vol.9 , pp. 342
    • Penn, L.1    White, M.2    Oldroyd, J.3    Walker, M.4    Alberti, K.G.5    Mathers, J.C.6
  • 85
    • 50849110824 scopus 로고    scopus 로고
    • General effect on high-risk persons when general practitioners are trained in intensive treatment of type 2 diabetes
    • Rasmussen SS, Glumer C, Sandbaek A, Lauritzen T, Borch-Johnsen K. General effect on high-risk persons when general practitioners are trained in intensive treatment of type 2 diabetes. Scand J Prim Health Care. 2008;26:166-73. doi:10.1080/02813430802264624
    • (2008) Scand J Prim Health Care , vol.26 , pp. 166-73
    • Rasmussen, S.S.1    Glumer, C.2    Sandbaek, A.3    Lauritzen, T.4    Borch-Johnsen, K.5
  • 86
    • 78651399787 scopus 로고    scopus 로고
    • Prevention of type 2 diabetes in a primary healthcare setting: Three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance
    • Japan Diabetes Prevention Program (JDPP) Research Group
    • Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tsuzaki K, et al; Japan Diabetes Prevention Program (JDPP) Research Group. Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance. BMC Public Health. 2011;11:40. doi:10.1186/1471-2458-11-40
    • (2011) BMC Public Health , vol.11 , pp. 40
    • Sakane, N.1    Sato, J.2    Tsushita, K.3    Tsujii, S.4    Kotani, K.5    Tsuzaki, K.6
  • 87
    • 66849118860 scopus 로고    scopus 로고
    • A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: Pronounced short-Term impact but long-Term adherence problems
    • Lindahl B, Nilsso n TK, Borch-Johnsen K, Rer ME, So derberg S, Widman L, et al. A randomized lifestyle intervention with 5-year follow-up in subjects with impaired glucose tolerance: pronounced short-Term impact but long-Term adherence problems. Scand J Public Health. 2009;37:434-42. doi:10.1177/1403494808101373
    • (2009) Scand J Public Health , vol.37 , pp. 434-442
    • Lindahl, B.1    Nilsson, T.K.2    Borch-Johnsen, K.3    Rer, M.E.4    Soderberg, S.5    Widman, L.6
  • 88
    • 84880271527 scopus 로고    scopus 로고
    • The healthy living partnerships to prevent diabetes study: 2-year outcomes of a randomized controlled trial
    • Katula JA, Vitolins MZ, Morgan TM, Lawlor MS, Blackwell CS, Isom SP, et al. The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial. Am J Prev Med. 2013;44:S324-32. doi:10.1016/j.amepre .2012.12.015
    • (2013) Am J Prev Med , vol.44 , pp. S324-S332
    • Katula, J.A.1    Vitolins, M.Z.2    Morgan, T.M.3    Lawlor, M.S.4    Blackwell, C.S.5    Isom, S.P.6
  • 89
    • 78650662421 scopus 로고    scopus 로고
    • Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? the Nepi ANtidiabetes StudY (NANSY) [Letter]
    • Lindblad U, Lindberg G, Msson NO, Ranstam J, Tyrberg M, Jansson S, et al. Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY) [Letter]. Diabetes Obes Metab. 2011;13:185-8. doi:10.1111/j.1463-1326.2010.01331.x
    • (2011) Diabetes Obes Metab , vol.13 , pp. 185-188
    • Lindblad, U.1    Lindberg, G.2    Msson, N.O.3    Ranstam, J.4    Tyrberg, M.5    Jansson, S.6
  • 90
    • 84861058620 scopus 로고    scopus 로고
    • Successful treatment of prediabetes in clinical practice: Targeting insulin resistance and -cell dysfunction
    • Armato J, DeFronzo RA, Abdul-Ghani M, Ruby R. Successful treatment of prediabetes in clinical practice: targeting insulin resistance and -cell dysfunction. Endocr Pract. 2012;18:342-50. doi:10.4158/EP11194.OR
    • (2012) Endocr Pract , vol.18 , pp. 342-350
    • Armato, J.1    Defronzo, R.A.2    Abdul-Ghani, M.3    Ruby, R.4
  • 92
    • 33645516747 scopus 로고    scopus 로고
    • Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
    • Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010:CD002967. doi:10.1002/14651858.CD002967.pub4
    • (2011) Cochrane Database Syst Rev , pp. CD002967
    • Salpeter, S.R.1    Greyber, E.2    Pasternak, G.A.3    Salpeter, E.E.4
  • 93
    • 84860746569 scopus 로고    scopus 로고
    • The effect of English-language restriction on systematic review-based meta-analyses: A systematic review of empirical studies
    • Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, et al. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 2012;28:138-44. doi:10.1017/S0266462312000086
    • (2012) Int J Technol Assess Health Care , vol.28 , pp. 138-144
    • Morrison, A.1    Polisena, J.2    Husereau, D.3    Moulton, K.4    Clark, M.5    Fiander, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.